Corporate Governance
Comprehensive Compliance Program
Effective: July 1, 2013
Introduction
MCP Pharmaceuticals, LLC (“MCP”) is a specialty pharmaceutical company focused on the development, manufacture, sales and marketing of specialty pharmaceutical products. MCP and its employees are committed to adopting the highest ethical standards in their dealings with patients, physicians and the community-at-large.
As such, MCP has developed a Comprehensive Compliance Program (“CCP”) in accordance with the “Compliance Program Guidance for Pharmaceutical Manufacturers,” published by the Office of the Inspector General, U.S. Department of Health and Human Services ( “OIG Guidance”), and Code on Interactions with Healthcare Professionals published by Pharmaceutical and Research Manufacturers of America or PhRMA (“PhRMA Code”).
Our Compliance Program, established by our Compliance Committee in conjunction with MCP senior management, is a central component of our commitment to the highest standards of corporate conduct.
Compliance Officer
MCP’s Compliance Officer and Compliance Committee are charged with overseeing the continued development and implementation of its CCP. The Compliance Officer and Compliance Committee have direct access to both the CEO and President and are charged with developing the standards of conduct issued as part of the CCP, directing auditing and monitoring activities, as appropriate, and implementing corrective measures, as necessary.
Comprehensive Compliance Plan
The primary purpose of MCP’s CCP is to promote the highest standards of ethical conduct and to help prevent and detect violations of law or company policy. The CCP is based on the OIG Guidance and PhRMA Code. However, as the OIG Guidance and PhRMA Code explicitly recognize, the implementation of a compliance program cannot guarantee that all improper employee conduct will be eliminated. Nonetheless, it is MCP’s expectation that its employees will comply with the CCP. MCP has developed a Code of Conduct and Ethics (the “Code”), as well as additional policies and procedures that have been established in support of that Code. The Code applies to all MCP employees.
While MCP is not a member of PhRMA, MCP has adopted and does adhere to the tenets of the PhRMA Code. All of MCP’s personnel are expected to adhere to the Code of Conduct and Ethics, the PhRMA Code and all applicable compliance policies and procedures. MCP will provide compliance awareness for all of its employees on all elements of the CCP as well as on applicable laws and regulations. In addition, the Company will conduct internal auditing and monitoring as necessary to evaluate compliance with company standards. It is expected that employees will report any compliance-related concerns.
As such, a non-retaliation policy is in effect at the Company. Employees may report their concerns either anonymously or directly to the Compliance Officer, Compliance Committee, any manager, or the Human Resources Department. In the event that MCP becomes aware of a violation of law, regulation, or company policy, MCP is committed to investigating the matter, and where appropriate, taking disciplinary action, and implementing corrective measures to prevent further such violations. In accordance with and as explicitly recognized in the OIG Guidance, MCP has tailored its CCP to fit its unique environment and size. Additionally, MCP’s CCP is a living program, constantly involving regular assessment and adjustment to ensure the Program is responsive to the Company’s evolving business and associated compliance risks.
Annual California Spending Limit
MCP has established annual spending limits as per California Business and Professional Code §119402(d)(1) for certain promotional activities directed toward healthcare professionals in California. This annual dollar limit is $2,000 excluding reasonable reimbursement for travel expenses. Spending limits are established as the maximum boundaries for spending, and do not represent a spending “goal” or “average.” In most cases, the Company spends significantly less per physician than the stated spending limit.
SB 1765 Declaration
As part of our ongoing efforts in the area of compliance, MCP has developed a Comprehensive Compliance Program (CCP) that is reasonably designed to prevent and detect violations of law or company policy. To the best of our knowledge, and based on our good faith understanding of the statutory requirements, we have established a CCP that is compliant with the requirements of California Health & Safety Code §§119400-119402. In making this Declaration of compliance, MCP is not asserting or making any representation that every employee, agent, contractor or partner will always fully comply with its CCP or that MCP can prevent individual employees from engaging in improper conduct.
While we are constantly reassessing our compliance program to improve it, government standards on compliance programs recognize that no program can completely prevent individual employees from improper conduct. Based upon our good faith understanding of the statutory requirement, and to the best of MCP’s knowledge, MCP declares that, as of the date of this declaration, we are, in all material respects, in compliance with our Comprehensive Compliance Program, as described here, and with California Health & Safety Code §§119400-119402. Ensuring ethical and legal conduct is an ongoing company commitment. The CCP is a dynamic program that will continue to evolve to meet the company’s compliance needs. MCP will assess its program as often as necessary, but at least once each year prior to July 1st.
MCP Pharmaceuticals July, 1, 2013
 |
Comprehensive Compliance Program Download In PDF Format |